Skip to content

RDLNetworkEcosystem

Sign in Get started

© 2026 Raw Data Library. All rights reserved.

About FAQ Privacy Terms Contact

Dose escalation of Oncaspar parameters — Mona Ali Mahmoud Assar | RDL Network

Home
Publications
Dose escalation of Oncaspar parameters

Shared by

Ralf Weiskirchen

Dose escalation of Oncaspar parameters

Dataset en

Authors

MA
Mona Ali Mahmoud Assar
MH
Martina Hüffel
MA
Mamdouh Afify

Abstract

1 min read

Results of dose escalation study using 3 different doses of Oncaspar. <br>

Discussion(0)

Sign in to like and join the discussion.

No comments yet. Be the first to comment.

Publication Info

DOI: 10.6084/m9.figshare.17032946.v3
Year
Published: —
Language: en

Dataset Details

Link Of The Paper: https://doi.org/10.6084/m9.figshare.17032946.v3

Timeline

Created:June 19, 2026

Related publications

Measured parameters of dose escalation of Oncaspar

Mona Ali Mahmoud Assar, Martina Hüffel, Mamdouh Afify, Ralf Weiskirchen, Albrecht Eisert, René H. Tolba, Julia Steitz

Measured parameters of dose escalation study of Oncaspar

Mona Ali Mahmoud Assar, Martina Hüffel, Mamdouh Afify, Ralf Weiskirchen, Albrecht Eisert, René H. Tolba, Julia Steitz

Results

Mona Ali Mahmoud Assar, Martina Hüffel, Mamdouh Afify, Ralf Weiskirchen, Albrecht Eisert, René H. Tolba, Julia Steitz

Results of histopathological analysis

Mona Ali Mahmoud Assar, Martina Hüffel, Mamdouh Afify, Ralf Weiskirchen, Albrecht Eisert, René H. Tolba, Julia Steitz

Abstract CT015: A phase 1 dose escalation study of TB-403 in pediatric relapsed or refractory medulloblastoma, neuroblastoma, Ewing sarcoma, or alveolar rhabdomyosarcoma

Giselle L. Saulnier Sholler, Dan G. Duda, Genevieve Bergendahl, David H. Ebb, Matija Snuderl, Theodore W. Laetsch, Jennifer Michlitsch, Derek Hanson, Michael S. Isakoff, Kevin Bielamowicz, Jacquline Kraveka, Peter Carmeliet, A. De Deene, Rakesh K. Jain